Fernando Cruz-Guilloty
Scientific Director, Oncology - Precision Medicine & Diagnostics Lead Johnson & Johnson Innovative Medicine
Seminars
Wednesday 4th February 2026
Liquid Biopsies in Drug Development: Where They Add Value Today & What Still Needs Work
2:20 pm
- Where liquid biopsies are currently delivering the most value across the drug development lifecycle, and where teams remain cautious
- What are the key practical challenges of integrating liquid biopsy endpoints into clinical development programs
- What needs to change, technically, operationally, or regulatorily, to enable broader and more confident adoption
Wednesday 4th February 2026
Evening Engager, Hosted by Foundation Medicine
7:05 pm
This session will bring together precision medicine experts to discuss how the latest generation of biomarkers are driving smarter trial enrollment and monitoring.
Enjoy dinner, networking, and a panel discussion on opportunities for emerging biomarkers to impact clinical trial design.
